Understanding Uterine Fibroid Embolization as a Treatment Option
Uterine fibroids are among the most frequently encountered benign tumors in gynecologic practice. While many individuals with fibroids remain asymptomatic, a significant number experience symptoms that meaningfully affect daily life. Heavy or prolonged menstrual bleeding, pelvic fullness, pressure on the bladder or bowel, and chronic discomfort are common reasons patients seek treatment. Over time, advances in minimally invasive medicine have expanded the range of options available beyond traditional surgery. One such option is uterine fibroid embolization (UFE), also known as uterine artery embolization.
UFE is an image-guided procedure designed to reduce fibroid-related symptoms by interrupting the blood supply that allows fibroids to grow and persist. Rather than removing fibroids or the uterus itself, the procedure targets the arteries feeding the fibroid tissue, leading to gradual shrinkage and symptom improvement. For many patients, this approach offers a balance between effectiveness and preservation of normal anatomy.
Contact the office of Dr. Sergei Sobolevsky, or call him directly at (718) 787-5559. Dr. Sergei’s office is conveniently located in downtown Brooklyn.
The Biological Basis for Fibroid Embolization
Fibroids develop from smooth muscle cells within the uterine wall and tend to recruit a dense arterial network as they enlarge. Compared with surrounding uterine tissue, fibroids are disproportionately dependent on this blood supply. Embolization takes advantage of this difference. By selectively blocking the uterine arteries, blood flow to fibroids is reduced to a level that causes ischemia within the fibroid tissue, while the uterus remains viable through collateral circulation.
This selective vulnerability is the reason embolization can be effective without compromising the overall function of the uterus. Over weeks to months following the procedure, fibroids typically soften and contract, leading to gradual relief of bleeding and pressure-related symptoms.
Who may Benefit from a UFE Procedure
UFE is most often considered for patients with symptomatic fibroids who wish to avoid major surgery or who prefer to preserve their uterus. It is commonly used in individuals experiencing heavy menstrual bleeding that has not responded to medical therapy, as well as those with bulk-related symptoms such as pelvic pressure or urinary frequency.
The procedure is particularly well suited for patients with multiple fibroids spread throughout the uterus, where surgical removal of individual lesions may be complex or incomplete. It may also be appropriate for patients with medical conditions that increase the risks associated with anesthesia or surgery. As with any intervention, careful evaluation is necessary to ensure embolization aligns with the patient’s overall health and long-term goals.
Evaluation Before Treatment
Before undergoing a UFE procedure, patients typically complete a thorough diagnostic workup. Pelvic MRI is often used to confirm the presence of fibroids, evaluate their size and location, and assess uterine and ovarian anatomy. Imaging also helps exclude alternative diagnoses that may require different management.
Equally important is a detailed discussion of treatment options. Medical therapy, surgical approaches such as myomectomy or hysterectomy, and embolization each carry distinct benefits and limitations. Fertility considerations, symptom severity, and tolerance for recovery time are all part of this shared decision-making process. Dr. Sergei Sobolevsky will help you through this process at his office located in downtown Brooklyn.
How the UFE Procedure is Performed
Uterine fibroid embolization is performed by an interventional radiologist in a specialized angiography suite. The procedure begins with access to the arterial system, most commonly through a small puncture in the groin or wrist. Using live imaging guidance, a catheter is navigated into the uterine arteries.
Once positioned, contrast imaging allows the physician to visualize the arterial branches supplying the fibroids. Embolic particles are then introduced through the catheter and carried by blood flow into the small vessels feeding the fibroids. These particles lodge in place, reducing circulation to the fibroid tissue. The process is repeated on both sides to ensure comprehensive treatment.
The procedure typically takes one to two hours. Because it does not involve surgical incisions in the abdomen or uterus, recovery is generally shorter than with operative approaches.
Recovery and Early Post-procedure Effects
Following embolization, patients commonly experience pelvic cramping and discomfort as the fibroids begin to lose their blood supply. This response is expected and usually most pronounced during the first day or two. Fatigue, low-grade fever, and mild nausea may also occur. Together, these symptoms are often referred to as post-embolization syndrome and are managed with medications and supportive care.
Most patients are able to resume light activities within several days and return to normal routines within one to two weeks. Menstrual cycles may change temporarily, with bleeding patterns stabilizing over the following months as fibroids continue to shrink.
Effectiveness and Long-term Outcomes
Clinical studies and long-term follow-up data indicate that the majority of appropriately selected patients experience substantial improvement after UFE. Heavy menstrual bleeding is often significantly reduced, and symptoms related to uterine bulk tend to diminish as fibroids decrease in size. Imaging follow-up typically demonstrates meaningful volume reduction over time.
While UFE does not prevent the development of new fibroids, many patients experience durable symptom control for years. In cases where symptoms recur, additional treatment options—including repeat embolization or surgery—may be considered.
Risks and Limitations
UFE has a well-established safety profile when performed by experienced practitioners. Minor complications such as bruising at the access site or temporary discomfort are relatively common, while serious complications are uncommon. Changes in ovarian function can occur, particularly in patients closer to natural menopause, and this possibility is discussed during pre-procedure counseling.
As with any medical treatment, UFE is not appropriate for every patient. Certain fibroid types or coexisting conditions may respond better to alternative therapies. For this reason, individualized assessment remains essential.
Comparing Fibroid Embolization with Surgery
Unlike hysterectomy, embolization preserves the uterus and avoids major abdominal surgery. Compared with myomectomy, embolization treats all fibroids simultaneously rather than targeting selected lesions. Each approach has advantages depending on the clinical situation, and embolization is best viewed as one component of a broader fibroid management strategy rather than a replacement for surgical care.
The Role of the Interventional Radiologist
UFE is performed by physicians trained in interventional radiology, a specialty focused on minimally invasive, image-guided therapies. Experience with pelvic vascular anatomy and embolization techniques is critical to achieving optimal outcomes. Collaboration between interventional radiologists and gynecologists ensures that patients receive balanced, comprehensive guidance.
Local Care in Downtown Brooklyn
In Downtown Brooklyn, uterine fibroid embolization is offered by specialists in vascular and interventional radiology, including Dr. Sergei Sobolevsky. His clinical practice emphasizes minimally invasive treatments guided by advanced imaging. Patients considering UFE typically undergo a consultation to review imaging findings, symptom history, and treatment goals before deciding whether embolization is an appropriate option. Reach out to Dr. Sobolevsky in downtown Brooklyn for a free consultaion.
Ongoing Care and Follow-up
After embolization, follow-up visits are used to assess symptom improvement and overall recovery. Imaging may be repeated several months after the procedure to document fibroid response. Continued gynecologic care remains important to monitor menstrual health and address any new concerns.
In summary, Uterine fibroid embolization represents a well-established, minimally invasive option for managing symptomatic fibroids. By addressing the vascular foundation of fibroid growth, the procedure offers symptom relief for many patients while preserving the uterus and reducing recovery time. When incorporated into a thoughtful, patient-centered treatment plan, UFE plays an important role in modern fibroid care.
Contact Dr. Sergei Sobolevsky, or call his office in downtown Brooklyn at (718) 787-5559.
Downtown Vein Treatment Center
480 Court Street, Ste 101
Brooklyn, NY 11231
(718) 787-5559